Jaipriya K S
Content Writer, siliconindia

Over the last decade, the vibrant landscape of entrepreneurial ecosystem of India enumerated a troop of high-net worth startups which are restructuring the diverse sectors & registering their success paradigms. Apart from achieving extensive financial success, the pioneering ventures represent the zenith of inventive vision & deliberated far-sightedness with a steadfast promise to push the boundaries & to mark a potential global influence of India. Through a powerful financial success, they have become a beacon of motivation for budding entrepreneurs spanning over the country. The net-worth they attained today is the keystone of their implementation of cutting-edge technologies, execution of their matchless brilliance & the potential to steer the complicated market landscape with well-made solutions.

So here, let’s explore the High-net worth startups in India emerged over the decade & making significant financial revolution in market with limitless innovation & commitment.

PharmEasy

Key Management: Dharmil Sheth & Dhaval Shah, Co-Founders

Competitors: Netmeds.com, Truemeds, Medlife, Mr. Med, Tablt, and Myra Medicines

Established with initial seed funding offered by the Co-founders’ parents in 2015, PharmEasy is an instrumental company revolutionizing the complete healthcare service in India. Since it is a new entry to the heathtech industry, PharmEasy has evolved as a leading digital healthcare platform of India that delivers healthcare products, diagnostic lab tests, online prescriptions, pharmaceuticals & tele-consultation across diverse categories with the help of trusted retail partners spanning over the country. In the year 2021, the company acquired its one of the key competitor Medlife & obtained a 66.1 percent stake of Rs. 4,546 crore in a diagnostic platform Thyrocare.

Over 17 funding rounds, PharmEasy has raised a total funding of $1.53 billion from 57 institutional investors & 77 angel investors. The latest funding round held on November 01, 2023, in which the company lifted $420 million fund from key investors such as LGT Capital Partners, ADQ, Amansa Capital, Orbimed, Eight Roads Ventures & so on.